2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)

Por: Zamorano, JL, Munoz, D, Aboyans, V, Asteggiano, R, Galderisi, M, Habib, G, Lenihan, DJ, Lip, GYH, Lyon, AR, Fernandez, TL, Mohty, D, Piepoli, MF, Tamargo, J, Torbicki, A, Suter, TM, Achenbach, S, Agewall, S, Badimon, L, Baron-Esquivias, G, Baumgartner, H, Bax, JJ, Bueno, H, Carerj, S, Dean, V, Gaemperli, O, Kirchhof, P, Kolh, P, Lancellotti, P, Nihoyannopoulos, P, Ponikowski, P, Roffi, M, Carneiro, AV, Windecker, S, Minotti, G, Cardinale, D, de Azambuja, E, Dent, S, Erol, C, Ewer, MS, Farmakis, D, Fietkau, R, Fitzsimons, D, McGale, P, Ringwald, J

---

Publicada: 1 ene 2017

---

---

Filiaciones:
Badimon, L:
 Institut dInvestigació Biomèdica Sant Pau IIB Sant Pau, Barceona, Spain

Lancellotti, P:
 Centre Hospitalier Universitaire de Liege, Liege, Belgium